112 related articles for article (PubMed ID: 33496681)
1. Erratum: Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure.
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33496681
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
[TBL] [Abstract][Full Text] [Related]
3. Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure.
Llewellyn SV; Conway GE; Shah UK; Evans SJ; Jenkins GJS; Clift MJD; Doak SH
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568251
[TBL] [Abstract][Full Text] [Related]
4. Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Oct; 834():35-41. PubMed ID: 30173862
[TBL] [Abstract][Full Text] [Related]
5. Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver.
Llewellyn SV; Conway GE; Zanoni I; Jørgensen AK; Shah UK; Seleci DA; Keller JG; Kim JW; Wohlleben W; Jensen KA; Costa A; Jenkins GJS; Clift MJD; Doak SH
J Nanobiotechnology; 2021 Jun; 19(1):193. PubMed ID: 34183029
[TBL] [Abstract][Full Text] [Related]
6. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Jan; 825():51-58. PubMed ID: 29307375
[TBL] [Abstract][Full Text] [Related]
7. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction.
Sun B; Liang Z; Wang Y; Yu Y; Zhou X; Geng X; Li B
Toxicology; 2024 Jun; 505():153829. PubMed ID: 38740170
[TBL] [Abstract][Full Text] [Related]
8. Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids.
Ma LD; Wang YT; Wang JR; Wu JL; Meng XS; Hu P; Mu X; Liang QL; Luo GA
Lab Chip; 2018 Aug; 18(17):2547-2562. PubMed ID: 30019731
[TBL] [Abstract][Full Text] [Related]
9. A 3D cell printing-fabricated HepG2 liver spheroid model for high-content in situ quantification of drug-induced liver toxicity.
Hong S; Song JM
Biomater Sci; 2021 Sep; 9(17):5939-5950. PubMed ID: 34318795
[TBL] [Abstract][Full Text] [Related]
10. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
11. Spheroid Formation and Evaluation of Hepatic Cells in a Three-Dimensional Culture Device.
Miyamoto Y; Ikeuchi M; Noguchi H; Yagi T; Hayashi S
Cell Med; 2015 Dec; 8(1-2):47-56. PubMed ID: 26858908
[TBL] [Abstract][Full Text] [Related]
12. Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model.
Elje E; Mariussen E; Moriones OH; Bastús NG; Puntes V; Kohl Y; Dusinska M; Rundén-Pran E
Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32197356
[TBL] [Abstract][Full Text] [Related]
13. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a functional C3A liver spheroid model.
Gaskell H; Sharma P; Colley HE; Murdoch C; Williams DP; Webb SD
Toxicol Res (Camb); 2016 Jun; 5(4):1053-1065. PubMed ID: 27746894
[TBL] [Abstract][Full Text] [Related]
15. Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells.
Baze A; Parmentier C; Hendriks DFG; Hurrell T; Heyd B; Bachellier P; Schuster C; Ingelman-Sundberg M; Richert L
Tissue Eng Part C Methods; 2018 Sep; 24(9):534-545. PubMed ID: 30101670
[TBL] [Abstract][Full Text] [Related]
16. Hepatic spheroid-on-a-chip: Fabrication and characterization of a spheroid-based
AlShmmari SK; Fardous RS; Shinwari Z; Cialla-May D; Popp J; Ramadan Q; Zourob M
Biomicrofluidics; 2024 May; 18(3):034105. PubMed ID: 38817733
[TBL] [Abstract][Full Text] [Related]
17. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
Štampar M; Tomc J; Filipič M; Žegura B
Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
[TBL] [Abstract][Full Text] [Related]
18. An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids.
Anada T; Fukuda J; Sai Y; Suzuki O
Biomaterials; 2012 Nov; 33(33):8430-41. PubMed ID: 22940219
[TBL] [Abstract][Full Text] [Related]
19. Assessing the transferability and reproducibility of 3D in vitro liver models from primary human multi-cellular microtissues to cell-line based HepG2 spheroids.
Llewellyn SV; Kermanizadeh A; Ude V; Jacobsen NR; Conway GE; Shah UK; Niemeijer M; Moné MJ; van de Water B; Roy S; Moritz W; Stone V; Jenkins GJS; Doak SH
Toxicol In Vitro; 2022 Dec; 85():105473. PubMed ID: 36108805
[TBL] [Abstract][Full Text] [Related]
20. 3D co-culturing model of primary pancreatic islets and hepatocytes in hybrid spheroid to overcome pancreatic cell shortage.
Jun Y; Kang AR; Lee JS; Jeong GS; Ju J; Lee DY; Lee SH
Biomaterials; 2013 May; 34(15):3784-94. PubMed ID: 23433671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
